Alcami appoints new CEO in Patrick Walsh, the executive who helped lead the CDMO's predecessor company
While North Carolina-based Alcami only came into existence back in 2016, the company has looked to keep expanding as the market for contract work in biopharma continues to grow. To get it there, it’s tapping an old friend — the executive who helped chart the company on its current path.
Alcami named Patrick Walsh as its newest CEO on March 18. Walsh previously served as CEO of AAI Pharma, the predecessor company that eventually became Alcami, between 2010 and 2014.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.